KEEL PHARMACEUTICALS

Keel Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat type 1 diabetes and other autoimmune diseases.

#SimilarOrganizations #People #More

KEEL PHARMACEUTICALS

Industry:
Biotechnology Pharmaceutical

Founded:
2002-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Status:
Active


Similar Organizations

amicus-therapeutics-logo

Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

nanomed-pharameceuticals-logo

Nanomed Pharameceuticals

NanoMed Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutic products to treat cancer and other diseases.

tolero-pharmaceuticals-logo

Tolero Pharmaceuticals

Tolero Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics to treat cancer and other life-threatening diseases.


Current Advisors List

denise-faustman_image

Denise Faustman Sci Advisor / Board of Director @ Keel Pharmaceuticals
Board_observer

Founder


not_available_image

Richard Hoffman

More informations about "Keel Pharmaceuticals"

Keel Pharmaceuticals Inc - Company Profile and News

Company profile page for Keel Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Keel Pharmaceuticals - Contacts, Employees, Board Members, …

Organization. Keel Pharmaceuticals . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor Profiles 1. …See details»

Keel Pharmaceuticals - Products, Competitors, Financials, …

About Keel Pharmaceuticals. Developer of therapies to treat the causes of autoimmune disease, including type 1 diabetes and other autoimmune diseases. The company's technology is …See details»

Keel Pharmaceuticals - Crunchbase

Keel Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat type 1 diabetes and other autoimmune diseases. New. Resources. ... Experience the new …See details»

Keel Pharmaceuticals - Drug pipelines, Patents, Clinical trials

Explore Keel Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, .See details»

KEEL PHARMACEUTICALS, INC. - CAMBRIDGE, MA - Company Profile

Keel Pharmaceuticals, Inc. was founded in 2002, and is located at 215 First St Ste 104 in Cambridge. It employs 11 employees and is generating approximately $770,000.00 in annual …See details»

Keel Pharmaceuticals Inc. in Cambridge, Massachusetts - EIN TaxId

Keel Pharmaceuticals Inc. sponsors an employee benefit plan and files Form 5500 annual return/report. As per our records, the last return (form 5500) was filed for year 2009. All Other …See details»

KEEL PHARMACEUTICALS INC Cambridge MA, 02142 - Company …

Free Business profile for KEEL PHARMACEUTICALS INC at 215 1st St, Cambridge, MA, 02142-1213, US. KEEL PHARMACEUTICALS INC specializes in: Pharmaceutical Preparations. This …See details»

Keel Pharmaceuticals CEO, Founder, Key Executive Team, Board of ...

Explore {Keel Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

KEEL PHARMACEUTICALS INC. - CAGE.report

Last Updated: 2020-02-26 04:14:57: Status Code: 0: Foreign/Domestic Designator Code : US F/DDC: 1: Type Code: 4: Country: UNITED STATES: Phone Contacts: 617-225-0834See details»

KEEL PHARMACEUTICALS INC. - HIPAASpace

KEEL PHARMACEUTICALS INC. BUSINESS ADDRESS EIN 010608846 An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used …See details»

Tigris Pharmaceuticals - Crunchbase

Tigris Pharmaceuticals, Ception Therapeutics, Celator Pharmaceuticals, and Keel Pharmaceuticals, Inc. are all part of the biopharmaceutical industry. Ception Therapeutics and …See details»

Why These Investment Firms Bet $400 Million On A Chinese

1 day ago Serial Salesman: Kailera CEO Ron Renaud has built and sold three biotechs, the last for $8.7 billion. “Companies get bought, they don’t get sold,” he says. But the obesity market’s …See details»

American Association of Pharmaceutical Scientists - AAPS

The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 10,000 members employed in academia, industry, government, …See details»

American Association of Pharmaceutical Scientists - AAPS

Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over …See details»

Keel Pharmaceuticals: 药物管线_专利_临床试验_投融营收

了解Keel Pharmaceuticals公司的药物管线,治疗领域,技术平台,以及它的。See details»

Home | GSK US

The homepage of the GSK USA website. April 09 2025 GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025 ; March 25 2025 …See details»

Annovex Pharma | 503B Outsourcing Facility

Annovex manufactures high quality compounded sterile and non-sterile pharmaceutical products for hospitals, 503A compounding pharmacies and other healthcare institutions. We are …See details»

Richard Hoffman - Crunchbase Person Profile

Organization Name . Title At Company . Start Date . End Date . Keel Pharmaceuticals . Co-Founder, President and CEO: Nov 2003: Dec 2008: Education. Edit Education Section. …See details»

Keel Further Strengthens Leadership Team with ... - Business Wire

Oct 22, 2024 Keel is a portfolio company of Arlington Capital Partners, a private investment firm in the Washington, D.C. area, specializing in government-regulated industries. About Keel.See details»

linkstock.net © 2022. All rights reserved